Scinai Immunotherapeutics Lt
-$7.2K
Net Activity
Data as of: 2026-03-31
Institutions Holding
4
Popularity Rank
#12588
Avg Weight
0.00%
Total Value
$14.9K
4 institutions currently hold SCNI, with 0 net buyers and 5 net sellers this quarter.
Institutional Moves (Q1 2026)
Significantly Decreased
Based on recent trading activity
Net Selling Institutions
5
Net Buying Institutions
0
Top 5 by Value
Across its top 4 institutional holders, SCNI's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 3/100, avg. turnover score 40/100).
+$0.0
Total Buy Value
$57.0K
Total Sell Value
0
Net Buyers
5
Net Sellers
SCNI does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.
13F data as of 2026-03-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/SCNI
No Form 144 planned sale filings in the last 90 days
2
Active 5%+ Holders
| Reporting Person | Type | Filing Date | % of Class |
|---|---|---|---|
| LCK JNK 1 LLC | 13G/A | 2026-07-09 | 6.3% |
| STONE DANIEL E. | 13G/A | 2026-07-01 | 9.9% |
No Form 8-K filings for this ticker
09073Q303
The most-added stocks by 13F institutions this quarter
Institutions Holding
6,151
Total reported value
$2.1T
3246 13F institutions increased their position this quarter
Institutions Holding
5,958
Total reported value
$1.5T
3029 13F institutions increased their position this quarter
Institutions Holding
5,766
Total reported value
$3.0T
2744 13F institutions increased their position this quarter
Access SCNI's institutional ownership data programmatically:
REST API
curl https://alphasmo.com/api/v1/market/stock/SCNICLI
npx alphasmo stocks get SCNI